Hunan Er-Kang Pharmaceutical Co., Ltd, at its Annual General Meeting of 2022 held on 18 May 2023, approved 2022 profit distribution plan. The detailed profit distribution plan are as follows: Cash dividend/10 shares (tax included) of CNY 0.30000000.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
2.61 CNY | 0.00% | -7.12% | -18.69% |
1st Jan change | Capi. | |
---|---|---|
-18.69% | 745M | |
+32.36% | 709B | |
+30.77% | 595B | |
-1.60% | 367B | |
+20.07% | 334B | |
+6.04% | 289B | |
+14.77% | 239B | |
+9.13% | 211B | |
-3.97% | 203B | |
+9.27% | 171B |
- Stock Market
- Equities
- 300267 Stock
- News Hunan Er-Kang Pharmaceutical Co., Ltd
- Hunan Er-Kang Pharmaceutical Co., Ltd Approves 2022 Profit Distribution Plan